<DOC>
	<DOCNO>NCT00396578</DOCNO>
	<brief_summary>The purpose study determine effect aerosolize antibiotic respiratory infection mechanically ventilate patients.We hypothesize aerosolized antibiotic , achieve high drug concentration airway , would effectively treat respiratory infection , decrease need systemic antibiotic decrease antibiotic resistance .</brief_summary>
	<brief_title>Aerosolized Antibiotics Respiratory Tract Infection Patients Mechanical Ventilation</brief_title>
	<detailed_description>In patient require mechanical ventilation , sign respiratory infection often persist despite treatment powerful antibiotic give patient 's vein . In trial , patient purulent secretion assign aerosolized antibiotic placebo randomize protocol . Neither patient doctor know patient receiving.Need systemic antibiotic determine clinical physician . Comparisons make placebo study drug effect pneumonia , respiratory sign infection , ability wean patient ventilator , systemic ( give vein ) antibiotic use development organism resistant antibiotic .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>mechanical ventilation great 3 day great equal 18 year age survival great 14 day great 2 cc tracheal secretions/4 hour allergy drug , pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>aerosolize antibiotic</keyword>
	<keyword>ventilator associate pneumonia</keyword>
	<keyword>clinical pulmonary infection score</keyword>
	<keyword>bacterial resistance</keyword>
</DOC>